Xiaoyang WANG

Professional Title: Associate Professor

Education: PhD

Supervisor Category: Master Supervisor

Research Fields: new veterinary drug formulations and veterinary drug pharmaceutics; metabolism and residual elimination of veterinary drug formulations

1. Introduction

Xiaoyang Wang, Master's degree, Associate Researcher, Master's Supervisor. Engaged in long-term research on new veterinary drug formulations and veterinary drug pharmaceutics, as well as research on the metabolism and residual elimination of veterinary drug formulations. In recent years, I have mainly participated in and researched the research and development of two first class national new veterinary drugs - Ethanamizuril and Ethanamizuril Solution, as well as the research and development of two second class national new veterinary drugs - Nizoxanide and Nizoxanide dry suspension. I have obtained a total of 4 new drug certificates and am mainly responsible for formulation, formulation quality research, and stability research. I have led multiple scientific research projects, including one National Natural Youth Fund, three residual standard revision projects of the Ministry of Agriculture and Rural Affairs, one special fund project for basic scientific research business expenses of central level public welfare research institutes, and multiple horizontal development projects. Published more than ten articles, including 8 as first author and corresponding author (6 included in SCI), obtained 9 patent authorizations, including 2 international patents, including 1 Japanese patent and 1 British patent, and participated in the compilation of the textbook "Pharmaceutics" for agricultural and forestry colleges.

2、Contact Information

021-34293396、18616367216

E-mail：wxy@shvri.ac.ac.cn; 18616367216@qq.com

3、Publications

(1). Cui Zhou a, b, 1 , Wenchong Ye a, b, 1 , Yongjun Cao c, 1 , Meizhu Wang a, b , Dongxia Qi b , Guohao Liao a , Houkai Li d , Weiping Huang a , Wenming Chen e, ***, Xiaoyang Wang b, f, **, Wen Zhou b, f, * A gulose moiety contributes to the belomycin (BLM) disaccharide selective targeting to lung cancer cell. [J] European Journal of Medicinal Chemistry 226 (2021) (IF 6.514)

(2). Xiaoyang Wang, Keyu Zhang, Mi Wang, Lifang Zhang, Chenzhong Fei, Chunmei Wang, Yingchun Liu, Feiqun Xue, Taijun Hang. Population pharmacokinetics of ethanamizuril in normal and coccidiosis-infected chickens through ultra-performance liquid chromatography-Tandem Mass Spectrometry.[J] Journal of Veterinary Pharmacology and Therapeutics, 2020-05-06,43(4): 331-338.

(3). Wang Xiaoyang,Zhao Juan,Wei Shuya,Wang Chunmei,Zhang Lifang,Wang Mi,Liu Yingchun,Fei Chenzhong,Xue Feiqun,Zhang Keyu. Determination of ethanamizuril, a novel triazine coccidiostat, in rat plasma by ultra-performance liquid chromatography system-tandem mass spectrometry and its application in a toxicological study.[J]. Biomedical chromatography : BMC,2019.

(4). Wang Xiaoyang,Wang Mi,Zhang Keyu,Hou Ting,Zhang Lifang,Fei Chenzong,Xue Feiqun,Hang Taijun. Determination of virginiamycin M1 residue in tissues of swine and chicken by ultra-performance liquid chromatography tandem mass spectrometry.[J]. Food chemistry,2018,250. （7.516, Top5%）